Overview of Dr. Ilson
Dr. David Ilson is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Monmouth. He received his medical degree from New York University Grossman School of Medicine and has been in practice 31 years. Dr. Ilson accepts several types of health insurance, listed below. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 14 doctors at Memorial Sloan Kettering Monmouth who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
160 East 53rd Street
New York, NY 10022
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
- NYU Grossman School of MedicineInternship, Internal Medicine, 1986 - 1987
- New York University School of MedicineClass of 1986
Certifications & Licensure
- FL State Medical License 2021 - Present
- NJ State Medical License 2018 - 2025
- NY State Medical License 1987 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Top Doctors: New York Metro Area Castle Connolly, 2007-2014
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
- Join now to see all
Clinical Trials
- Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer Start of enrollment: 1997 Jun 01
- Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus Start of enrollment: 1997 Aug 01
- Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors Start of enrollment: 1998 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophage...Lisa A Kachnic, Kathryn Winter, Mohan Suntharalingam, David Ilson, André Konski
Quality of Life Research. 2024-10-01 - 2 citationsZolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma.Kohei Shitara, Manish A Shah, Florian Lordick, Eric Van Cutsem, David H Ilson
The New England Journal of Medicine. 2024-09-26 - Top advances of the year: Gastroesophageal cancer.Karyn A Goodman, Alexandra Hotca, Mengyuan Liu, Vivian E Strong, David H Ilson
Cancer. 2024-07-01
Press Mentions
- ESMO 2022: New Research in Treating Gastrointestinal and Genitourinary CancersNovember 10th, 2022
- Immune Checkpoint, VEGFR Inhibitor Combo Effective in Advanced Esophageal CancerJanuary 10th, 2022
- Breakthrough Research from Baylor Scott & White Health Transforms the Future of Cancer CareJuly 29th, 2021
- Join now to see all
Insurance Accepted
- BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPOMultiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: